Cardiology

A Mayo Clinic cardiologist discusses the national variability in CPR and AED access, and the actions that saved Hamlin's life during Monday Night Football.

Jesse Morse, MD, a sports medicine specialist, discusses commotio cordis and how to effectively communicate with athletes and parents of young athletes about the diagnosis in the wake of an incident where a player collapsed during a recent NFL game.

This cardiology case report from Brady Pregerson, MD, features a patient in their early 70s presenting to the hospital with reports of shortness of breath, palpitations, and chest pain. Can you determine the correct diagnosis?

A group of investigators, researchers and policymakers discuss the issues, innovations and aspirations that may define 2023 advances.

To celebrate the end of 2022 and the advances witnessed in the past year, our editorial team has created a list of the 5 most popular pieces of content related to endocrinology from 2022.

From a topical gene therapy to a debated heart failure option, a litany of unique agents are anticipated for FDA decision in the new year.

Our editorial team is celebrating the end of 2022 by recapping our most popular content from the 3 largest cardiology meetings from the past year.

With less than a week to go until the close of 2022, our editorial team is celebrating the final week of the year by recapping some of our most popular stories and content from the past year. Here, we are highlighting our most popular episodes of the Don’t Miss a Beat Podcast from 2022.

For the final week of the year, our editorial team is recapping our the most talked about phase 3 trial news, approvals, and CRLs related to cardiometabolic health in 2022, including empagliflozin, bempedoic acid, mavacamten, and more!

Our editorial team is kicking off the final week of the year by recapping our most popular case reports from Brady Pregerson, MD, from the past year.

The December 2022 cardiology month in review features the announcement of CLEAR Outcomes meeting its primary end point, a pair of new scientific statements from the American Heart Association, and more!

As physician demands continue to climb in the high-demand specialty, patient-reported outcomes have emerged as a viable tool in assessment and care.

An observational study of data from patients with cancer treated with immune checkpoint inhibitors provides an overview of prognostic utility of noncardiac biomarkers for predicting myocarditis and all-cause mortality.

On December 16, the world's foremost cardiology organizations released a joint opinion statement calling for a reinvention of clinical trials to better suit the needs of the healthcare system in the 21st century.

Negative perceptions of cardiology and a shift in preferences among internal medicine residents could be driving potential fellows away from careers in cardiology, according to a new study.

Released on December 12, the ACC's "Global Burden of Cardiovascular Diseases and Risks Collaboration" report provides an overview of trends in cardiovascular disease from 21 distinct regions defined by location and income level.

The advisory committee voted 3-8 against the benefit-risk profile of omecamtiv mecarbil for heart failure with reduced ejection fraction.

Beginning January 1, 2023, all new content and insights from the editorial teams of Practical Cardiology, Endocrinology Network and Rheumatology Network will be hosted on HCPLive.Com.

Published on December 12, the American Heart Association's scientific statement on diagnosis and management of acute coronary syndromes in older adults provides a review of several important topics including physiological changes, the influence of common geriatric syndromes, and age-appropriate and guideline-concordant recommendations for this patient population.

Drs Erin Michos, Pam Taub, Robert Busch, Alison Bailey, and Jorge Plutzky offer key takeaways in the management of hypercholesterolemia and ASCVD.

An expert panel discusses challenges and provides solutions to managing patients with hypercholesterolemia.

Our latest case report features a woman in her mid-70s presenting to the hospital with lightheadedness that came on gradually during brunch. Check out the ECG and determine the correct diagnosis!

They also found no statistically significant associations found for specific cardiovascular outcomes in relation to cardiac arrest or arrhythmias, cerebrovascular diseases, or myocardial infarction.

Our panel highlights the importance of a team-based approach to care in the management of hypercholesterolemia.

Erin D. Michos, MHS, FACC, FASPC; Pam Taub, MD, FACC, FASPC; Robert Busch, MD; Alison Bailey, MD, FACC; and Jorge Plutzky, MD; provide an overview of upcoming treatment options for managing hypercholesterolemia.

Gregory Weiss, MD, provides insight into his perspective on the evolving recognition of the role of sleep health in cardiovascular disease prevention.

A cluster randomized trial from Penn Medicine's Nudge Unit provides insight into the effects of "nudges" in primary care settings for improving the prescription of statins.

Leveraging data from the DASH trial, investigators from Beth Israel Deaconess Medical Center provides insight into the impact of different dietary approaches on 10-year ASCVD risk score among patients within the trial.

An analysis of data from patients admitted to emergency departments from 7 hospitals in Sweden provide insight into the potential of blood glucose at admission for use as a biomarker to predict all-cause mortality and cardiovascular risk in patients without a history of diabetes.